Lotus Bio-Technology Development Corp.
LBTD · OTC
3/31/2017 | 3/31/2016 | 3/31/2015 | 3/31/2014 | |
|---|---|---|---|---|
| Market Cap | $11,589 | $20,694 | $18,128 | $181 |
| - Cash | $0 | $0 | $2 | $0 |
| + Debt | $6 | $51 | $0 | $34 |
| Enterprise Value | $11,595 | $20,745 | $18,126 | $215 |
| Revenue | $0 | $0 | $0 | $0 |
| % Growth | – | – | – | – |
| Gross Profit | $0 | $0 | $0 | $0 |
| % Margin | – | – | – | – |
| EBITDA | -$20 | -$780 | -$19 | -$42 |
| % Margin | – | – | – | – |
| Net Income | -$20 | -$781 | -$19 | -$42 |
| % Margin | – | – | – | – |
| EPS Diluted | -0 | -0.009 | -0 | -0 |
| % Growth | 97.9% | -9,300% | 50% | – |
| Operating Cash Flow | -$18 | -$8 | $2 | -$25 |
| Capital Expenditures | $0 | -$7 | $0 | $0 |
| Free Cash Flow | -$18 | -$15 | $2 | -$25 |